Reading view
PRAISE: Prefix-Based Rollout Reuse in Agentic Search Training
3D-IDE: 3D Implicit Depth Emergent
Determined by User Needs: A Salient Object Detection Rationale Beyond Conventional Visual Stimuli
LightThinker++: From Reasoning Compression to Memory Management
BAAI Cardiac Agent: An intelligent multimodal agent for automated reasoning and diagnosis of cardiovascular diseases from cardiac magnetic resonance imaging
Agentization of Digital Assets for the Agentic Web: Concepts, Techniques, and Benchmark
GA-GS: Generation-Assisted Gaussian Splatting for Static Scene Reconstruction
Justified or Just Convincing? Error Verifiability as a Dimension of LLM Quality
Cardinality Estimation for High Dimensional Similarity Queries with Adaptive Bucket Probing
Your Agent, Their Asset: A Real-World Safety Analysis of OpenClaw
Xpertbench: Expert Level Tasks with Rubrics-Based Evaluation
Document Parsing Unveiled: Techniques, Challenges, and Prospects for Structured Information Extraction
Certified Training with Branch-and-Bound for Lyapunov-stable Neural Control
Human-AI Collaborative Game Testing with Vision Language Models
MoltNet: Understanding Social Behavior of AI Agents in the Agent-Native MoltBook
Security Considerations for Artificial Intelligence Agents
HISA: Efficient Hierarchical Indexing for Fine-Grained Sparse Attention
NSUN2/ALYREF-mediated RNA m5c modification promotes anoikis resistance of prostate cancer through activating autophagy
Oncogene, Published online: 07 April 2026; doi:10.1038/s41388-026-03762-4
NSUN2/ALYREF-mediated RNA m5c modification promotes anoikis resistance of prostate cancer through activating autophagyDecoding macrophage heterogeneity in the pulmonary fibrosis lung cancer transition
Front Immunol. 2026 Mar 20;17:1787094. doi: 10.3389/fimmu.2026.1787094. eCollection 2026.
ABSTRACT
Pulmonary fibrosis (PF) significantly increases the risk of lung cancer (LC), but the mechanisms underlying this transition remain unclear. This overview positions macrophage heterogeneity as a central node within the PF-LC continuum. First, we describe important subpopulations of profibrotic and pro-tumor macrophages, including SPP1+, MERTK+, TREM2+, and MARCO+ cells, using high-resolution spatial and single-cell omics technologies. Next, we analyze the fundamental mechanisms that determine their function: the fibrotic microenvironment (e.g., extracellular matrix stiffness, hypoxia) induces profound metabolic reprogramming (e.g., Warburg effect, lipid peroxidation) and stabilizes epigenetic memory (e.g., DNA methylation, histone modifications), locking them into a pathogenic state. This reprogramming occurs through two main pathways: (1) metabolic reprogramming, characterized by aerobic glycolytic conversion and dysregulated lipid metabolism, which stimulates both pathogenic functions and suppression of T cell activity; (2) Epigenetic modifications, including stabilized alterations in DNA methylation, histone modifications, and superactivator patterns, which maintain cells in a tumor-promoting phenotype. As central nodes of communication, these macrophages interact pathologically with fibroblasts and epithelial cells through secreted factors and extracellular vesicles, forming self-reinforcing feedback loops that promote disease progression. We are studying the crucial role of new technologies, particularly multi-omic spatial models and high-precision organoids, in fostering mechanistic discoveries. These discoveries pave the way for new macrophage-focused therapeutic strategies, including the precise stratification of patients using biomarkers from liquid biopsies (such as soluble SPP1 and MARCO) and the development of targeted drug delivery systems for the selective modulation of macrophage function, thus establishing a new paradigm for therapeutic interventions in pulmonary fibrosis with concomitant lung cancer.
PMID:41939908 | PMC:PMC13046558 | DOI:10.3389/fimmu.2026.1787094